Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$162 Mln
Revenue (TTM)
$301 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
2.5
Industry P/E
--
EV/EBITDA
11.1
Div. Yield
0 %
Debt to Equity
6.2
Book Value
$0.4
EPS
$-0.1
Face value
--
Shares outstanding
127,503,059
CFO
$-124.81 Mln
EBITDA
$-149.83 Mln
Net Profit
$-462.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Beauty Health Co (SKIN)
| -15.1 | 18.1 | -21.3 | -10.6 | -52.9 | -36.3 | -- |
|
BSE Sensex
| -9.4 | -8.1 | -9.3 | 3.4 | 9.8 | 9.0 | 12.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Beauty Health Co (SKIN)
| -12.6 | -48.6 | -65.8 | -62.3 | 113.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Beauty Health Co (SKIN)
|
1.2 | 161.9 | 300.8 | -9.5 | 3.9 | -16.8 | -- | 2.5 |
| 19.9 | 923.1 | 2,167.9 | -38.2 | 2.9 | -2.5 | 179.6 | 0.6 | |
| 88.1 | 2,933.8 | 1,488.5 | 168.4 | 16.3 | 20.7 | 17.5 | 3.3 | |
| 7.2 | 476.8 | 1,485.2 | 160.2 | 14.2 | 22 | 4.5 | 0.4 | |
| 60.0 | 926.5 | 478.9 | 51.5 | 13.3 | 19.4 | 17.5 | 3.6 | |
| 1.3 | 803.3 | 423.0 | -9.3 | 3.8 | -1.1 | -- | 0.9 | |
| 0.3 | 25.5 | 4.8 | 0.0 | -7.9 | -151.6 | -- | 0.0 | |
| 2.3 | 38.4 | 0.3 | -19.1 | -4,112.8 | -72.9 | -- | 1.0 | |
| 219.5 | 3,043.2 | 620.9 | 89.5 | 16.6 | 34.4 | 34.1 | 11.5 | |
| 3.6 | 623.2 | 4,181.0 | -78.7 | -2.3 | -2.6 | -- | 0.9 |
The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship... product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California. Read more
President, CEO & Director
Ms. Marla Malcolm Beck
President, CEO & Director
Ms. Marla Malcolm Beck
Headquarters
Long Beach, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Beauty Health Co (SKIN) is $1.18 (NASDAQ) as of 18-Mar-2026 16:00 EDT. Beauty Health Co (SKIN) has given a return of -52.92% in the last 3 years.
Since, TTM earnings of Beauty Health Co (SKIN) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-19.90
|
3.09
|
|
2024
|
-7.76
|
4.36
|
|
2023
|
-4.10
|
6.91
|
|
2022
|
30.66
|
8.12
|
|
2021
|
-6.51
|
8.15
|
The 52-week high and low of Beauty Health Co (SKIN) are Rs 2.69 and Rs 0.78 as of 19-Mar-2026.
Beauty Health Co (SKIN) has a market capitalisation of $ 162 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Beauty Health Co (SKIN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.01
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.